Loading…
Loading…
Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
taxon 292Also known as: Pseudomonas cepacia, Pseudomonas kingii, Pseudomonas multivorans
No local or indigenous names recorded yet.
Not yet assessed
Occurrence records: Recorded mostly outside Africa. 48 of 828 GBIF records (6%) are from Africa (checked 10/12/2026). A hint from GBIF and the genomes on this Hub, not an assessment: GBIF includes zoo and travel records.
Species that share this one's nearest groups in NCBI Taxonomy. This is how they're classified, not a phylogeny. See it in the species tree.
Origin: hub
35 downloads
First synced: 10/11/2026 · Last updated: 10/12/2026
Source: NCBI GCF_914492715.1 · View at source ↗
Download annotation (GFF3) · Download CDS (FASTA) · Download proteins (FASTA)
Collection: Cameroon
Sequencing: Illumina Hiseq 2500 Paired ends (2 x 125) · CLC-Genomic Workbench · 250x coverage
Released: 2021-09-14 · Submitted by: Institut de Recherche pour le Developpement
publiccc0AFDSI-SEQ-6135 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: CM · PIC: unknown · MAT: unknown
GoaT: no record for this species (not eukaryotic, or not yet sequenced)
Publicly accessible — no request needed.
ppnP — 106 aa
murE — 512 aa
pyrG — 552 aa
ftsH — 660 aa
poxB — 573 aa
rlmN — 379 aa
glmU — 453 aa
katG — 728 aa
def — 504 aa
coaBC — 403 aa
Origin: hub
0 downloads
First synced: 11/8/2026 · Last updated: 11/8/2026
Source: NCBI MG575434.1 · View at source ↗
Collection: China
Released: 2018-09-29
publiccc0AFDSI-SEQ-6515 Benefit-sharing under CBD Decision 16/2 and national frameworks →Country of origin: CN · PIC: unknown · MAT: unknown
Publicly accessible — no request needed.
AlphaFold DB proteome: UP000218103 ↗
PaxDb — real per-protein abundance
ahpC_2 (292.WI67_10305) — abundance 33638AFDSI-PROTEOMICS-651
hupB (292.WI67_00455) — abundance 26837AFDSI-PROTEOMICS-652
AOI87283.1 (292.WI67_31875) — abundance 24670AFDSI-PROTEOMICS-653
groS (292.WI67_04130) — abundance 22475AFDSI-PROTEOMICS-654
AOI81352.1 (292.WI67_02260) — abundance 20026AFDSI-PROTEOMICS-655
AOI85163.1 (292.WI67_22075) — abundance 11982AFDSI-PROTEOMICS-656
AOI82542.1 (292.WI67_08870) — abundance 11547AFDSI-PROTEOMICS-657
ompA_2 (292.WI67_05020) — abundance 9938AFDSI-PROTEOMICS-658
AOI81816.1 (292.WI67_04830) — abundance 9433AFDSI-PROTEOMICS-659
AOI83407.1 (292.WI67_13605) — abundance 9432AFDSI-PROTEOMICS-660
PRIDE — project-level reference (metadata only; no per-protein identifications are available via PRIDE's public API)
Quorum sensing and DNA methylation play active roles in clinical Burkholderia phase variation (PXD055955) ↗AFDSI-PROJREF-594
Identifying the glycoproteome of Burkholderia cenocepacia following knockdown of glycosylation using CRISPR interference (low dCas9 induction) (PXD040181) ↗AFDSI-PROJREF-595
A Dataset for Developing Proteomic Tools in Pathogen Detection via Differential Cell Lysis from Whole Blood Samples (PXD039165) ↗AFDSI-PROJREF-596
Identifying the glycoproteome of Burkholderia cenocepacia following knockdown of glycosylation using CRISPR interference (low dCas9 induction) - loading control for glycopeptide enrichment (PXD038044) ↗AFDSI-PROJREF-597
Direct comparison between a Burkholderia cenocepacia glycosylation mutant, and a CRISPRi-mediated glycosylation knockdown strain (PXD038043) ↗AFDSI-PROJREF-598
Identifying the glycoproteome of Burkholderia cenocepacia following knockdown of glycosylation using CRISPR interference - loading control for glycopeptide enrichment (PXD037749) ↗AFDSI-PROJREF-599
Analysing the glycoproteome of Burkholderia diffusa following knockdown of glycosylation using CRISPR interference (PXD037750) ↗AFDSI-PROJREF-600
Analysing the glycoproteome of Burkholderia cenocepacia following knockdown of glycosylation using CRISPR interference (PXD037778) ↗AFDSI-PROJREF-601
Identifying the glycoproteome of Burkholderia cenocepacia following knockdown of glycosylation using CRISPR interference (low dCas9 induction) (PXD038047) ↗AFDSI-PROJREF-1021
Analysing the glycoproteome of Burkholderia multivorans following knockdown of glycosylation using CRISPR interference (PXD037777) ↗AFDSI-PROJREF-1022
ChEMBL rows are compounds active against a protein target from this organism — not confirmed as compounds the species itself produces, unlike ANPDB's.
ChEMBL: CHEMBL541279 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 3.1 ug.mL-1AFDSI-METABOLOMICS-1338
ChEMBL: CHEMBL4524121 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 100.0 ug.mL-1AFDSI-METABOLOMICS-1332
ChEMBL: CHEMBL4524118 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 100.0 ug.mL-1AFDSI-METABOLOMICS-1333
ChEMBL: CHEMBL4524119 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 100.0 ug.mL-1AFDSI-METABOLOMICS-1334
ChEMBL: CHEMBL4524120 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 100.0 ug.mL-1AFDSI-METABOLOMICS-1335
ChEMBL: CHEMBL542832 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 6.2 ug.mL-1AFDSI-METABOLOMICS-1336
ChEMBL: CHEMBL541279 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 3.1 ug.mL-1AFDSI-METABOLOMICS-1337
ChEMBL: CHEMBL544247 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 6.2 ug.mL-1AFDSI-METABOLOMICS-1339
ChEMBL: TEMAFLOXACIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 12.5 ug.mL-1
MetaboLights: Analysis of 3274 bacterial isolates by rapid evaporative ionisation mass spectrometry (REIMS) (View at source ↗)AFDSI-METABPROF-220
pLDDT confidence: 94.8
Auto-synced from AlphaFold DB AF-A0A102PHK2-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-15292-V2pLDDT confidence: 96.0
Auto-synced from AlphaFold DB AF-A0A081VA81-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-15272-V2pLDDT confidence: 92.5
Auto-synced from AlphaFold DB AF-A0A102R9D1-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-15274-V2pLDDT confidence: 90.3
Auto-synced from AlphaFold DB AF-A0AAP4VLW5-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-15276-V2pLDDT confidence: 93.3
Auto-synced from AlphaFold DB AF-A0AAQ0JL81-F1 · View at source ↗
publiccc_byAFDSI-STRUCT-15278-V2No African occurrence records found for this species in GBIF — please confirm this is within this platform's African-origin/endemic/indigenous scope. This is a non-blocking, informational check only: GBIF coverage is real but imperfect, so a genuinely African species can still show no records here.
A node's own derived bioinformatics-analysis output (e.g. an SSR/microsatellite discovery archive) run against this species' own genome data — see the Derived Analysis page for the full catalog.
MegaSSR — ssr_discovery
derived from genome record AFDSI-SEQ-6135
File: GCF_914492715.1_megassr_results.tar.gz
Tool version: MegaSSR v3.0.0 (UM6P patched)
Native — captured by Northern-MA-UM6P-8787752738 · View at source ↗
cc_by public Country of origin not recorded: see how benefit-sharing works →
AFDSI-ANALYSIS-20801There are more related species. Open the species tree to see them all.
ChEMBL: (S)-TEMAFLOXACIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 6.2 ug.mL-1AFDSI-METABOLOMICS-1343
ChEMBL: CHEMBL49071 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 12.5 ug.mL-1AFDSI-METABOLOMICS-1345
ChEMBL: CHEMBL544247 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 6.2 ug.mL-1AFDSI-METABOLOMICS-1340
ChEMBL: TEMAFLOXACIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 12.5 ug.mL-1AFDSI-METABOLOMICS-1342
ChEMBL: (S)-TEMAFLOXACIN (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 6.2 ug.mL-1AFDSI-METABOLOMICS-1344
ChEMBL: CHEMBL49071 (View at source ↗) — Target organism (ChEMBL) — not confirmed as a compound this species produces; MIC 12.5 ug.mL-1AFDSI-METABOLOMICS-1346